|
S100P expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.382200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.326400E-01 |
| Normal-vs-Stage2 |
2.409600E-01 |
| Normal-vs-Stage3 |
2.657200E-01 |
| Normal-vs-Stage4 |
2.176000E-01 |
| Stage1-vs-Stage2 |
7.089400E-01 |
| Stage1-vs-Stage3 |
3.971800E-01 |
| Stage1-vs-Stage4 |
3.577400E-01 |
| Stage2-vs-Stage3 |
5.537800E-01 |
| Stage2-vs-Stage4 |
2.519800E-01 |
| Stage3-vs-Stage4 |
1.938580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.427000E-01 |
| Normal-vs-AfricanAmerican |
2.144400E-01 |
| Normal-vs-Asian |
1.910200E-01 |
| Caucasian-vs-AfricanAmerican |
5.853900E-02 |
| Caucasian-vs-Asian |
1.202550E-03 |
| AfricanAmerican-vs-Asian |
7.348100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.457400E-01 |
| Normal-vs-Female |
2.251200E-01 |
| Male-vs-Female |
2.346200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.418600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.377800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.252600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.483400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.264600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.331400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.752400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.730200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.591800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.188400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.822000E-01 |
| Normal-vs-Grade 2 |
2.465800E-01 |
| Normal-vs-Grade 3 |
2.285600E-01 |
| Normal-vs-Grade 4 |
2.388800E-01 |
| Grade 1-vs-Grade 2 |
4.451800E-01 |
| Grade 1-vs-Grade 3 |
2.387600E-01 |
| Grade 1-vs-Grade 4 |
2.988800E-01 |
| Grade 2-vs-Grade 3 |
4.700000E-01 |
| Grade 2-vs-Grade 4 |
7.424000E-01 |
| Grade 3-vs-Grade 4 |
6.467000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.258600E-01 |
| Normal-vs-ccB subtype |
2.580600E-01 |
| ccA subtype-vs-ccB subtype |
3.107800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.559200E-01 |
| Normal-vs-N1 |
3.389200E-01 |
| N0-vs-N1 |
2.395600E-01 |
|
|
